Active Ingredient: Brensocatib
Brensocatib is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in patients 12 years of age and older with two or more exacerbations in the prior 12 months.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Oral, 25 milligrams brensocatib, once daily.
Η συνιστώμενη δόση είναι 25 mg από στόματος μία φορά ημερησίως με ή χωρίς τροφή.
Οι ασθενείς που παραλείπουν μια δόση θα πρέπει να λαμβάνουν την επόμενη δόση κατά τη συνήθη ώρα την επόμενη ημέρα. Οι ασθενείς δεν θα πρέπει να διπλασιάζουν τη δόση για να αναπληρώσουν τη δόση που παραλείφθηκε.
Δεν απαιτείται προσαρμογή της δόσης για τους ηλικιωμένους ασθενείς.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.